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Abstract
Several lines of evidence suggest that genome-wide association studies (GWAS) have the potential to explain more of the
‘‘missing heritability’’ of common complex phenotypes. However, reliable methods to identify a larger proportion of single
nucleotide polymorphisms (SNPs) that impact disease risk are currently lacking. Here, we use a genetic pleiotropy-informed
conditional false discovery rate (FDR) method on GWAS summary statistics data to identify new loci associated with
schizophrenia (SCZ) and bipolar disorders (BD), two highly heritable disorders with significant missing heritability.
Epidemiological and clinical evidence suggest similar disease characteristics and overlapping genes between SCZ and BD.
Here, we computed conditional Q–Q curves of data from the Psychiatric Genome Consortium (SCZ; n = 9,379 cases and
n = 7,736 controls; BD: n = 6,990 cases and n = 4,820 controls) to show enrichment of SNPs associated with SCZ as a function
of association with BD and vice versa with a corresponding reduction in FDR. Applying the conditional FDR method, we
identified 58 loci associated with SCZ and 35 loci associated with BD below the conditional FDR level of 0.05. Of these, 14
loci were associated with both SCZ and BD (conjunction FDR). Together, these findings show the feasibility of genetic
pleiotropy-informed methods to improve gene discovery in SCZ and BD and indicate overlapping genetic mechanisms
between these two disorders.
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to explain a greater proportion of the heritability of common
complex phenotypes [4–6], and more SNPs are likely to be
identified in larger samples [7]. Due to the polygenic nature of
most complex traits and disorders, a large number of SNPs are
likely to have associations too small in magnitude to be identified
with currently available sample sizes [8]. New analytical methods
are therefore needed to reliably identify a larger proportion of
SNPs associated with complex diseases and phenotypes, since
recruitment and genotyping of sufficiently large samples for
existing methods may be impractical and prohibitively expensive.

Introduction
Converging evidence suggests that complex human phenotypes
are influenced by numerous genes each explaining a small
proportion of the variance [1]. Though thousands of single
nucleotide polymorphisms (SNPs) have been identified by genomewide association studies (GWAS) [2,3], these SNPs fail to explain a
large proportion of the heritability of most complex phenotypes
studied. This is commonly referred to as the ‘missing heritability’
problem. Recent findings indicate that GWAS have the potential
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Manual of Mental Disorders (DSM), this question has received
renewed attention [19,20,23]. Both disorders have an estimated
heritability of 0.7–0.8, and are regarded as complex disorders with
a polygenic architecture. Several lines of evidence have suggested
overlapping genetic susceptibility in bipolar disorder and schizophrenia [15,24–26]. Recently, a combined analysis of two large
GWAS (16,374 cases and 12,044 controls) revealed three loci
(CACNA1C, rs4765905, p = 7.061029, ANK3 rs10994359,
p = 2.561028, ITIH3/4 region rs2239547, p = 7.861029) significantly associated with both disorders (Fisher’s combined p in
combined samples) [13,14]. Still, given the high degree of
heritability and large similarities in clinical phenotypes, there are
likely several more undiscovered overlapping genetic factors.
Here, using summary statistics from two independent large
GWAS, we applied a model-free statistical analysis method to
identify SNPs exhibiting pleiotropic relationships between schizophrenia and bipolar disorder. First, we separated out the common
controls in the bipolar disorder and schizophrenia samples [13,14],
ensuring non-overlapping samples. After applying genomic
inflation control, we computed the conditional empirical cumulative distribution functions (cdfs) of the corrected p-values.
Empirical cdfs for schizophrenia SNP p-values were determined
conditional on the significance of the corresponding nominal pvalues in bipolar disorder, and vice versa. For each nominal p-value,
an estimate of the conditional False Discovery Rate (FDR) was
obtained from the conditional empirical cdfs [5]. Using this
conditional FDR method, we constructed two-dimensional FDR
‘‘look-up’’ tables, with FDR in schizophrenia SNPs computed
conditional on nominal bipolar disorder p-values, and vice versa.
Using these tables we identified 58 loci associated with schizophrenia and 35 loci associated with bipolar disorder at a
conditional FDR level of 0.05. We used a conjunction method to
investigate SNPs significantly associated with both schizophrenia
and bipolar disorder. Specifically, we computed the conditional
FDR for schizophrenia given bipolar disorder nominal p-values,
and conditional FDR for bipolar disorder given schizophrenia
nominal p-values, and took the maximum of both values as the
conjunction FDR. With this approach we identified 14 pleiotropic
loci indicating several overlapping genetic risk factors for the two
disorders. Finally, using mixture model-based analyses we
estimated the proportion and distribution of non-null SNPs,
demonstrating that the large increase in power from using
conditional vs. unconditional FDR methods is derived from the
high polygenicity of both phenotypes with many test statistics just
below significance thresholds, and the largely overlapping
distribution (high degree of pleiotropy) of non-null SNPs for
schizophrenia and bipolar disorder.

Author Summary
Genome-wide association studies (GWAS) have thus far
identified only a small fraction of the heritability of
common complex disorders, such as severe mental
disorders. We used a conditional false discovery rate
approach for analysis of GWAS data, exploiting ‘‘genetic
pleiotropy’’ to increase discovery of common gene variants
associated with schizophrenia and bipolar disorders.
Leveraging the increased power from combining GWAS
of two associated phenotypes, we found a striking overlap
in polygenic signals, allowing for the discovery of several
new common gene variants associated with bipolar
disorder and schizophrenia that were not identified in
the original analysis using traditional GWAS methods.
Some of the gene variants have been identified in other
studies with large targeted replication samples, validating
the present findings. Our pleiotropy-informed method
may be of significant importance for detecting effects that
are below the traditional genome-wide significance level
in GWAS, particularly in highly polygenic, complex
phenotypes, such as schizophrenia and bipolar disorder,
where most of the genetic signal is missing (i.e., ‘‘missing
heritability’’). The findings also offer insights into mechanistic relationships between bipolar disorder and schizophrenia pathogenesis.
Genetic pleiotropy is defined as a single gene or variant being
associated with more than one distinct phenotype. In the present
study we use a new genetic pleiotropy-informed approach for
GWAS to capture more of the polygenic effects in complex
phenotypes. Given the high number of traits in humans, and the
relatively small number of genes (,20,000), some genes have to
affect multiple traits (genetic pleiotropy) [10]. By combining
independent GWAS from associated disorders, we hypothesize
that for disorders with related etiologies a genetic pleiotropyinformed approach can significantly improve gene discovery and
help capture more of the missing heritability.
Recent findings suggest overlapping SNPs between several
human traits [9,11] and disorders [12–14]. To date, methods to
assess this genetic pleiotropy have not taken full advantage of the
existing GWAS data and the majority of studies have focused on
the subset of SNPs exceeding a Bonferroni-corrected threshold of
significance for each trait or disorder [12–14]. However, this
approach cannot detect SNPs that only reach genome-wide
significance in the combined analysis but do not meet Bonferronicorrected significance in the individual phenotype (hereafter
referred to as polygenic pleiotropy). Combining GWAS statistics
from two disorders also provides increased power to discover genes
associated with common biological mechanisms, and thus inform
on overlapping pathophysiological relationships between the
disorders. In the current study, we use a pleiotropy-informed
statistical approach to improve gene discovery in schizophrenia
and bipolar disorder, two disorders with high heritability [15],
where most of the underlying genetic architecture remains
unknown [13,14], despite recent discoveries [13,14,16,17].
Schizophrenia and bipolar disorder share several clinical
characteristics [18–20], including psychotic symptoms, disorders
of thought and impairment of cognitive functions [21]. The
disorders are often also treated with similar pharmacological
agents [18,19]. Whether schizophrenia and bipolar disorder
should be regarded as separable disease entities or as a single
disease with a spectrum of symptoms [18–20], as proposed in the
continuum hypothesis of psychosis [22], has been much discussed.
With the forthcoming revision of the Diagnostic and Statistical
PLOS Genetics | www.plosgenetics.org

Results
Q–Q plots of schizophrenia SNPs conditional on
association with bipolar disorder and vice versa
Under large-scale testing paradigms, such as GWAS, quantitative estimates of likely true associations can be estimated from
distributions of summary statistics [27,28]. A common method for
visualizing the ‘enrichment’ of statistical association relative to that
expected under the global null hypothesis is through Q-Q plots of
nominal p-values obtained from GWAS summary statistics. The
usual Q-Q curve has the nominal p-value, denoted by ‘‘p’’, as the
y-ordinate and the corresponding value of the empirical cdf, here
denoted by ‘‘q,’’ as the x-ordinate. Under the global null
hypothesis the theoretical distribution is uniform on the interval
[0,1]. As is common in GWAS, we instead plot 2log10 p against
2log10 q to emphasize tail probabilities of the theoretical and
2
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Figure 1. Stratified Q–Q plot and Stratified True Discovery Rate plots. Upper panel: Stratified Q-Q plot of nominal versus empirical 2log10 pvalues (corrected for inflation) in A) schizophrenia (SCZ) below the standard GWAS threshold of p,561028 as a function of significance of the
association with bipolar disorder (BD) at the level of 2log10(p).0, 2log10(p).1, 2log10(p).2, 2log10(p).3 corresponding to p,1, p,0.1, p,0.01,
p,0.001, respectively, and in B) BD below the standard GWAS threshold of p,561028 as a function of significance of association with SCZ at the
level of 2log10(p).0, 2log10(p).1, 2log10(p).2, 2log10(p).3 corresponding to p,1, p,0.1, p,0.01, p,0.001, respectively. Dotted lines indicate
the null-hypothesis. Lower panel: Stratified True Discovery Rate (TDR) plots illustrating the increase in TDR associated with increased pleiotropic
enrichment in C) SCZ conditional on nominal BD p-values (SCZ|BD), and D) BD conditional on nominal SCZ p-values (BD|SCZ). For more information
about QQ plots, see Text S1.
doi:10.1371/journal.pgen.1003455.g001

nominal schizophrenia p-value. Successive leftward shifts for
decreasing nominal bipolar disorder p-value thresholds indicate
that the proportion of non-null effects in schizophrenia varies
considerably across different levels of association with bipolar
disorder. For example, the proportion of SNPs in the 2log10(pBD)
$3 category reaching a given significance level for schizophrenia
(e.g., 2log10(pSCZ) $4) is roughly 50 times greater than for the
2log10(pBD) $0 category (all SNPs), indicating a high level of
enrichment. An even stronger pleiotropic enrichment can be seen
for bipolar disorder conditioned on nominal p-values of association with schizophrenia (BD|SCZ; Figure 1B), Here, the
proportion of SNPs in the 2log10(pSCZ) $3 category reaching a
given significance level for bipolar disorder (e.g., 2log10(pBD)$4) is
roughly 500 times greater than for the 2log10(pSCZ)$0 category
(all SNPs), indicating a very high level of enrichment.

empirical distributions. As such, genetic ‘enrichment’ refers to a
leftward shift in the Q-Q curve, corresponding to a larger fraction
of SNPs with nominal 2log10 p-value greater than or equal to a
given threshold. Conditional Q-Q plots are formed by creating
subsets of SNPs based on values of an additional variable (auxiliary
measure) for each SNP, and computing Q-Q plots separately for
each subset of SNPs. If SNP enrichment is captured by variation in
the auxiliary measure, this is expressed as successive leftward
deflections in conditional Q-Q plots as values of the additional
variable increase.
Conditional Q-Q plots for schizophrenia given nominal pvalues of association with bipolar disorder (SCZ|BD; Figure 1A)
show enrichment across different levels of significance for bipolar
disorder. The earlier departure from the null line (leftward shift)
suggests a greater proportion of true associations for a given
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using standard methods based on p-values (Bonferroni correction).
Using the FDR method in bipolar disorder alone, an additional
locus was identified, close to CACNA1C (12p13.3). Both these loci
have been discovered earlier [14,31]. The remaining 33 loci would
not have been identified in the current sample without using the
pleiotropy-informed conditional FDR method. Of these, the regions
close to SYNE1 (6q25) and ODZ4 (11q14.1) have been identified in
earlier GWAS after including large replication samples [14,32]. Of
interest, the ITIH3 region (3p21.1), ANK3 (10q21) and CACNA1C
(12p13.3) were discovered previously in the same, combined
schizophrenia and bipolar disorder sample [13,14]. Thus, pleiotropy-informed conditional FDR validated 5 loci discovered in
considerably larger samples, and discovered 30 new loci.

Conditional True Discovery Rate (TDR) in schizophrenia
is increased by bipolar disorder, and vice versa. Since

categories of SNPs with stronger pleiotropic enrichment are more
likely to be associated with schizophrenia, to maximize power for
discovery all tag SNPs should not be treated exchangeably.
Specifically, variation in enrichment across pleiotropic categories
is expected to be associated with corresponding variation in the
TDR (equivalent to 1-FDR) [29] for association of SNPs with
schizophrenia. A conservative estimate of the TDR for each
nominal p-value is equivalent to 1 – (p/q), easily read off from
conditional Q-Q plots (see Material and Methods). This relationship
is shown for schizophrenia conditioned on nominal bipolar disorder
p-values (SCZ|BD; Figure 1C) and bipolar disorder conditioned on
nominal schizophrenia p-values (BD|SCZ; Figure 1D). For a given
conditional TDR the corresponding estimated nominal p-value
threshold varies with a factor of 100 from the most to the least
enriched SNP category for schizophrenia conditioned on bipolar
disorder (SCZ|BD), and approximately a factor of 500 for bipolar
disorder conditioned on schizophrenia (BD|SCZ).

Pleiotropic gene loci in both schizophrenia and bipolar
disorder identified with conjunctional FDR
To identify pleiotropic loci in schizophrenia and bipolar
disorder, we performed a conjunction FDR analysis, using this
to construct a ‘‘conjunction’’ Manhattan plot (Figure 4). We
detected 14 independent pleiotropic loci (pruned based on
LD.0.2, black line around large circles) with conjunction
FDR,0.05, all single gene loci, located on a total of 10
chromosomes (chr. 1, 3, 6, 7, 10, 12, 14, 16, 20, 22 – for further
details, please see Table 3). Of these loci, 3 have been implicated
in bipolar disorder and schizophrenia earlier: NOTCH4 (6p21.2)
with schizophrenia using a larger replication sample [13,17], and
the ITIH4 (3p21.1), and CACNA1C (12p13.3) regions, both
discovered previously in the same, combined schizophrenia and
bipolar disorder sample [13,14]. Interestingly only one conjunctional locus was found on chromosome 6, suggesting that there are
several schizophrenia loci on this chromosome not overlapping
with bipolar disorder. The ANK3 locus was not indicated in the
conjunctional analysis, which indicates that the overlap is mostly
driven by the association in bipolar disorder (Table 2). The
direction of the effect (z-scores) across all the pleiotropic SNPs was
the same for bipolar disorder and schizophrenia, except for locus
33 (BC039673, 20p13), which could be due to differences in LD
structure in this region. These findings suggest overlapping genetic
pathways in schizophrenia and bipolar disorders.

Schizophrenia gene loci identified with conditional FDR
We constructed a ‘‘conditional’’ Manhattan plot for schizophrenia showing the FDR conditional on bipolar disorder
(Figure 2) and identified significant loci on a total of 18
chromosomes (1–4, 6–16, 18, 20 and 22) associated with
schizophrenia leveraging the reduced FDR obtained by the
associated bipolar disorder phenotype. To estimate the number
of independent loci, we ‘pruned’ the associated SNPs (removed
SNPs with linkage disequilibrium (LD).0.2), and identified a total
of 58 independent loci with a significance threshold of conditional
FDR,0.05 (Table 1). Using the more conservative conditional
FDR threshold of 0.01, 9 independent loci remained significant.
One locus was located in the HLA region on chromosome 6. Of
note, using a standard Bonferroni-corrected approach, no loci
would have been discovered. Using the FDR method in
schizophrenia alone, 4 loci were identified. Of these, the regions
close to TRIM26 (6p21.3), MMP16 (8q21.3) and NT5C2
(10q24.32) have been identified in earlier GWAS studies after
including large replication samples [13]. The remaining loci would
not have been identified in the current sample without using the
pleiotropy-informed conditional FDR method. Of interest, the
VRK2 region (2p16.1) was identified in the previous sample after
including a large schizophrenia replication sample [30], and the
ITIH4 region (3p21.1), ANK3 (10q21) and CACNA1C (12p13.3)
were discovered previously in the same, combined schizophrenia
and bipolar disorder sample [13,14]. Thus, the current pleiotropyinformed FDR method validated 7 loci discovered in considerably
larger samples, and discovered 51 new loci.

Model-based power analyses
Our model-free conditional FDR analyses circumvent the issue
of bias due to model misspecification. However, to ascertain the
impact of effective sample size and conditioning on relative power
over using unconditioned FDR on current sample sizes, it is
necessary to use a model-based approach that estimates the
proportion and distribution of non-null SNPs [33]. We thus posit a
mixture of null and non-null Gaussian distributions [34] (see
Methods and Text S1). Resulting model fits are displayed in
Figure 5 for schizophrenia and bipolar disorder for absolute z
scores $3. Left panels are actual data, whereas right panels are
hypothetical realizations from a doubling of effective sample size,
generated from mixture model fits. Null densities largely coincide
with the overall densities except for z scores with absolute value
larger than 4, at which point the ratio of null to total SNPs, equal
to the local false discovery rate (local FDR), is less than 0.5 (left panels
of Figure 5). Thus, while highly polygenic, most non-null SNPs
have local FDR much larger than 0.05. The local FDR does not
drop below 0.05 until absolute z scores exceed 5. Far more of the
‘‘hidden’’ non-null SNPs lie below this significance threshold than
above it. Many of these hidden SNPs lie just below the significance
threshold, so that an effective doubling of the sample size produces
a ,30 times increase in number of rejected non-null SNPs with
local FDR #0.05 (right panels of Figure 5).

Bipolar disorder gene loci identified with conditional FDR
We constructed a ‘‘conditional’’ Manhattan plot for bipolar
disorder showing the FDR conditional on schizophrenia (Figure 3)
and identified significant loci on a total of 16 chromosomes (1–3,
5–8, 10–14, 16 and 19–22) associated with bipolar disorder
leveraging the reduced FDR obtained by the associated schizophrenia phenotype. To estimate the number of independent loci,
we pruned the associated SNPs (removed SNP with LD .0.2), and
identified a total of 35 independent loci with a significance
threshold of conditional FDR,0.05 (Table 2). Of these, one locus
was complex, i.e. included several significant SNPs, and the rest
were single gene loci. Using the more conservative conditional
FDR threshold of 0.01, 5 independent loci remained significant.
The most significant locus was close to ANK3 on chromosome
(10q21). This is the only locus that would have been discovered
PLOS Genetics | www.plosgenetics.org
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Figure 2. ‘‘Conditional Manhattan plot’’ of conditional 2log10 (FDR) values for schizophrenia (SCZ) alone (black) and SCZ given
bipolar disorder (BD; SCZ|BD, red). SNPs with conditional 2log10 FDR.1.3 (i.e. FDR,0.05) are shown with large points. A black line around the
large points indicates the most significant SNP in each LD block and this SNP was annotated with the closest gene, which is listed above the symbols
in each locus. The figure shows the localization of significant loci. Details about the loci are provided in Table 1.
doi:10.1371/journal.pgen.1003455.g002

samples, and demonstrate how GWAS from associated psychiatric
disorders can improve discovery of novel susceptibility loci. Using
standard GWAS analytical methods, we identified only one
significant locus. By applying traditional FDR methods in the
separate GWAS samples, we found an additional 6 loci (2 in
bipolar disorder, 4 in schizophrenia). Combining the independent
schizophrenia and bipolar disorder GWAS samples, we identified
a total of 58 loci in schizophrenia and 35 in bipolar disorders, with
conditional FDR,0.05 as a threshold. Nine of the current loci
have been identified earlier in larger samples using standard
GWAS analytical methods (7 in schizophrenia, 5 in bipolar
disorder, and 3 in combined samples), while 10 other loci have
been reported to show borderline association with bipolar disorder
or schizophrenia (Table S1). These results demonstrate the
feasibility of using a cost-effective, pleiotropy-informed conditional
FDR approach to discover common variants in schizophrenia and
bipolar disorders.
The proposed statistical approach is based on the observation
that all SNPs should not be treated as exchangeable. Rather, a
SNP with large effects in two associated phenotypes has a higher
probability of being a true non-null effect, and hence also a higher
probability of being replicated in independent studies. We thus
applied a conditional FDR approach we have previously
developed for GWAS p-values [36], adapted from methods
originally used for linkage analysis and microarray expression
data [5,37]. Decreased conditional FDR (equivalently, increased
conditional TDR) for a given nominal p-value increases power to
detect true non-null effects. Increased conditional TDR is directly
related to increased replication effect sizes and replication rates in
de novo samples. Using this conditional approach we were able to
increase power to detect true non-null signals in independent
studies for given nominal p-values cut-offs. Equivalently, in the

Another model-based analysis using a bivariate mixture of
Gaussians showed that a very high proportion of the non-null
schizophrenia SNPs are also non-null for bipolar disorder (and vice
versa) leading to large increases in power when using the
conditional FDR approach. This increase in power is also due
to the large number of SNPs with p-values just below the
Bonferroni threshold. Figure 6 shows the power, or sensitivity to
detect non-null SNPs for differing local FDR cut points from
unconditional and conditional local FDR and, for comparison,
from a hypothetical doubling of the number of subjects. Using
conditional over unconditional local FDR results in an increase of
15–20 times the number of non-null SNPs discovered for a local
FDR#0.05. The increase in power for conditional FDR, while
dramatic, is not as large as what would be obtained by doubling
the sample size. This is not unexpected, given that the highly
polygenic non-null SNPs for schizophrenia and bipolar disorder,
many just below the given significance thresholds, are largely but
not completely overlapping. Note, given their highly polygenic
distribution the vast majority of non-null SNPs remain undiscovered even using conditional FDR approaches or under an effective
doubling of the number of subjects.
To test for enrichment with a ‘‘control trait’’ with little or no
polygenic overlap with psychiatric disease, we performed pleiotropy analysis using type 2 diabetes (T2D) GWAS data. The
analyses confirmed that there was a very small level of pleiotropic
enrichment between schizophrenia and T2D, leading to little if
any improvement in statistical power (See Text S1 and Figure S7).

Discussion
In the present study we leveraged the power of GWAS data
from two independent schizophrenia and bipolar disorder
PLOS Genetics | www.plosgenetics.org
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Table 1. Conditional FDR; SCZ loci given BD (SCZ|BD).

Locus

SNP

neighbor gene

chr

pval SCZ

fdr SCZ

fdr SCZ|BD

1

rs2252865

2

rs11579756

RERE

1p36.23

4.76E-04

0.377

0.030

KIAA1026

1p36.21

1.17E-04

0.203

3

0.037

rs4949526

BC042538

1p35.2

1.11E-04

0.181

0.035

4

rs4650608

IFI44

1p31.1

2.06E-04

0.257

0.028

5

rs4907103

LPAR3

1p22.3

9.77E-05

0.181

0.039

6

rs1625579

AK094607

1p21.3

3.76E-06

0.065

0.011

7

rs11205362

PRP3

1q21.1

1.11E-03

0.489

0.033

8

rs10495658

RAD51AP2

2p24.2

.3.99E-05

0.115

0.044

9

rs813592

GCKR

2p23

2.71E-05

0,095

0.014

10

rs10189138

VRK2{

2p16.1

1.42E-04

0.229

0.038

11

rs11692886

SH3RF3

2q13

1.05E-04

0.181

0.035

12

rs6435387

KIF5C

2q23.1

4.28E-05

0.115

0.020

13

rs17180327

CWC22

2q31.3

1.29E-05

0.080

0.038

14

rs17662626

PCGEM1

2q32

7.79E-05

0.161

0.030

15

rs2675968

C2orf82

2q37.1

5-64E-05

0-143

0-021

16

rs4663627

AGAP1

2q37

1.31E-04

0.203

0.033

17

rs13072940

TRANK1

3p22.2

1.27E-05

0.080

0.013

18

rs4687657

ITIH4{

3p21.1

1.56E-04

0.229

0.028

19

rs11130874

PTPRG

3p21-p14

9.45E-06

0.077

0.030

20

rs9838229

DKFZp434A128

3q26.33

2.89E-05

0.104

0.045

21

rs13150700

SORBS2

4q35.1

2.77E-04

0.286

0.048

22

rs9379780

SCGN

6p22.3-p22.1

3.78E-06

0.065

0.024

rs198829

HIST1H2BC

6p22.1

2.18E-05

0.088

0.027

rs7749823

HIST1H2BD

6p21.3

1.32E-07

0.014

0.005

rs17693963

BC035101

6p22.1

1.87E-07

0.022

0.001

rs13190937

ZSCAN23

6p22.1

1.23E-04

0.203

0.033

rs3130893

ZNF311

6p22.1

3.83E-06

0.065

0.006

rs2523722

TRIM26{

6p21.32-p22.1

2.54E-07

0.025

0.001

rs2596565

MICA

6p21.33

9.33E-06

0.077

0.009

rs2284178

HCP5

6p21.3

3.31E-04

0.316

0.036

rs805294

LY6G6C

6p21.33

1.11E-04

0.181

0.039

rs9268858

HLA-DRA

6p21.3

1.66E-05

0.084

0.041

rs9268862

HLA-DRA

6p21.3

6.21E-07

0.037

0.002

rs502771

HLA-DRB5

6p21.3

2.97E-05

0.104

0.039

rs9276601

HLA-DQB2

6p21

3.07E-05

0.104

0.015

rs7383287

HLA-DOB

6p21.3

2.71E-05

0.095

0.019

rs1480380

HLA-DMA

6p21.3

1.06E-05

0.077

0.010

24

rs9462875

CUL9

6p21.1

1.61E-04

0.229

0.036

25

rs7787274

FTSJ2

7p22

3.27E-04

0.316

0.028

26

rs12543276

AK055863

8p23.1

1.38E-04

0.203

0.046

27

rs7004633

MMP16{

8q21.3

1.70E-07

0.018

0.005

28

rs2254884

ABCA1

9q31.1

1.17E-04

0.203

0.032

29

rs6602217

AK094154

10p14

2.29E-05

0.095

0.015

30

rs7084499

ANK3{

10q21

1.74E-04

0.229

0.040

31

rs2153522

ANK3{

10q21

7.92E-04

0.449

0.046

32

rs7895695

RRP12

10q24.1

3.57E-05

0.115

0.018

33

rs2298278

SUFU

10q24.32

1.24E-03

0.527

0.037

rs10883817

CNNM2

10q24.32

1.13E-05

0.080

0.020

rs11191580

NT5C2{

10q24.32

1.71E-06

0.049

0.005

23
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Table 1. Cont.

Locus

SNP

neighbor gene

chr

pval SCZ

fdr SCZ

fdr SCZ|BD

34

rs4356203

PIK3C2A

11p15.5-p14

5.48E-05

0.128

0.029

35

rs676318

LRP5

11q13.4

1.41E-05

0.080

0.023

36

rs6591348

GAL

11q13.3

1.16E-05

0.080

0.027

37

rs17126243

LOC399959

11q24.1

1.29E-05

0.080

0.027

38

rs11222395

SNX19

11q25

1.36E-04

0.203

0.032

39

rs7106715

IGSF9B

11q25

6.52E-05

0.143

0.039

40

rs7972947

CACNA1C{

12p13.3

5.32E-07

0.035

0.013

41

rs1006737

CACNA1C

12p13.3

3.52E-05

0.104

0.022

42

rs4517638

DAOA

13q34

1.10E-05

0.077

0.015

43

rs961196

TTC7B

14q32.11

3.07E-03

0.662

0.044

44

rs1502404

TMCO5A

15q14

1.04E-03

0.489

0.040

45

rs724729

C15orf54

15q14

4.70E-05

0.128

0.038

46

rs1869901

PLCB2

15q15

2.03E-04

0.257

0.039

47

rs2414718

BC033962

15q22.2

4.59E-05

0.128

0.025

48

rs1051168

NMB

15q22

1.27E-04

0.203

0.033

49

rs1078163

NTRK3

15q25

2.67E-05

0.095

0.017

50

rs2304634

DNAJA3

16p13.3

7.90E-05

0.161

0.026

51

rs12708772

SHISA9

16p13.12

3.12E-03

0.662

0.044

52

rs4785714

ZNF276

16q24.3

1.34E-03

0.527

0.034

53

rs12966547

AK093940

18q21.2

6.23E-06

0.071

0.019

54

rs159788

BC039673

20p13

1.23E-03

0.527

0.034

55

rs381523

PPM1F

22q11.22

1.55E-03

0.560

0.038

56

rs9621795

LARGE

22q12.3

1.66E-05

0.084

0.041

57

rs5758209

EP300

22q13.2

5.06E-06

0.068

0.031

58

rs28729663

RPL23AP82

22q13.33

1.82E-04

0.257

0.041

Independent complex or single gene loci (r2,0.2) with SNP(s) with a conditional FDR (condFDR),0.05 in schizophrenia (SCZ) given the association in bipolar disorder
(BD). We defined the most significant SCZ SNP in each LD block based on the minimum condFDR for BD. The most significant SNPs in each LD block are listed. All loci
with SNPs with condFDR,0.05 were used to define the number of the loci. Chromosome location (Chr). SCZ FDR values,0.05 are in bold.
{
Same locus identified in previous SCZ genome-wide association studies. All data were first corrected for genomic inflation.
doi:10.1371/journal.pgen.1003455.t001

roughly 1.2% of tag SNPs are non-null in both bipolar disorder
and schizophrenia. With over 1 million assayed SNPs in common
between both phenotypes, the number of un-pruned, non-null
SNPs is thus in excess of 12,000 in each phenotype. The vast
majority of these non-null SNPs are hidden within the large
proportion (,99%) of null SNPs. Results are in line with recent
findings of a high proportion of variation in schizophrenia
susceptibility captured by common SNPs [6]. Taken together,
these findings strongly suggest that Empirical Bayes methods, as
outlined by Efron [27] should be the method of choice for
analyzing GWAS of polygenic human phenotypes, and for
leveraging pleiotropy with other complex humans traits.
The current findings of polygenic enrichment suggest that
genetic pleiotropy is important in severe mental disorders, as has
been indicated earlier [13–15,24,25]. However, by using conditional FDR, we were able to leverage the overlapping polygenetic
architecture to identify more of the specific SNPs involved. The
current approach identified 58 loci in schizophrenia compared to
7 in the original publication [13]. In bipolar disorder, the added
power from schizophrenia GWAS identified 35 loci compared to
two loci in the original study [14]. It is important to note that this
improvement in gene discovery was obtained despite the much
smaller number of controls in the current analyses because the
original analyses of the two disorders used largely overlapping

conditional approach the FDR can be used to control FDR at a
given level while increasing power to discover non-null SNPs over
approaches that treat all SNPs as interchangeable. We also applied
a previously developed conjunction FDR approach [36] to
investigate which SNPs are pleiotropic, impacting risk of both
schizophrenia and bipolar disorder. The conjunction statistic used
is the maximum of the conditional FDR for schizophrenia given
bipolar disorder and vice versa. SNPs that exceed a stringent
conjunction threshold are thus highly likely to be non-null in the
two phenotypes simultaneously.
The extra number of significant loci identified in the current
study compared to ‘conventional’ GWAS methods is remarkable.
The power analyses suggest that the large increase in power is due
to the conditional FDR method, and not an implicit higher false
discovery rate. Compared to conventional GWAS methods,
traditional FDR methods only identified a few extra loci. The
large increase in power came from using conditional FDR, which
identified 14.5 times as many schizophrenia SNPs and 17.5 times
as many bipolar SNPs (at FDR#.05 level) compared to traditional
FDR methods. This large increase in power seems to be due to two
factors: the highly polygenic distribution of non-null SNPs and the
high degree of pleiotropy between schizophrenia and bipolar
disorder. We quantified this using a model-based mixture of null
and non-null Gaussian distributions [34]. Mixture models estimate
PLOS Genetics | www.plosgenetics.org
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Figure 3. ‘‘Conditional Manhattan plot’’ of conditional 2log10 (FDR) values for Bipolar disorder (BD) alone (black) and BD given
schizophrenia (SCZ; BD|SCZ, blue). SNPs with conditional 2log10 FDR.1.3 (i.e. FDR,0.05) are shown with large points. A black line around the
large points indicates the most significant SNP in each LD block and this SNP was annotated with the closest gene, which is listed above the symbols
in each locus. The figure shows the localization of significant loci. Details about the loci are provided in Table 2.
doi:10.1371/journal.pgen.1003455.g003

implicated in bipolar disorder [26,40]. The current findings
strengthen the involvement of genes related to calcium homeostasis and receptor functioning. In schizophrenia, both CACNA1C
and ANK3 were identified, and in bipolar disorder TRANK1 and
CACNB2 were also significantly associated. CACNA1C and
CACNB2 are related to key proteins involved in unifying the
generation of calcium spikes in neocortical pyramidal neurons,
which is a closely integrated process [41]. It is likely that such
functional processes could be involved in generation of symptoms
in severe mental disorders, and may thus be a potential therapeutic
target. Interestingly, PPM1F, a Mg2+/Mn2+ dependent protein
phosphatase, related to calcium/calmodulin-dependent protein
kinase II gamma, was also associated with both disorders, and
seems to further strengthen the hypothesis that alterations in
electrophysiological function play a role in the pathophysiology of
these disorders. It is also noteworthy that SNPs located close to
MAD1L1 were significantly associated with both schizophrenia
and bipolar disorder. MAD1L1 is located in a human accelerated
region in the genome, which shows a large difference between
humans and chimpanzees [42], and thus is suggested to be
involved in human-specific traits.
In addition to uncovering more of the missing heritability of
bipolar disorder and schizophrenia, the current findings support
the notion that genetic pleiotropy is important for variation in
human phenotypes [9], and suggest that there is substantial
polygenic pleiotropy between bipolar disorder and schizophrenia
which warrants further exploration. In the current study we
defined pleiotropy as a single gene or variant being associated with
more than one distinct phenotype (diseases) [9]. It is possible that
some of the loci identified in the current study are not pleiotropic
but rather underlie common aspects of the schizophrenia and

control samples. Since we used data from the 1000 Genomes
Project (1KGP) to calculate LD structure, the number of loci can
vary somewhat compared to the original analysis. For both
disorders, most of the current findings were borderline significant
in the original GWAS mega-analysis, or identified in other GWAS
of partly overlapping samples, such as TRANK1 [38] and SYNE1
[32]. Several of the currently identified genes have been associated
in previous candidate gene studies, such as DAOA [39].
Further, we identified 14 loci strongly associated with both
disorders, compared to three in the original combined analysis
[13,14]. Previous studies have mainly used Fisher combined tests
for joint analysis, which test the null-hypothesis of no association in
any phenotype, which means that the signal can be driven by one
of the phenotypes. In contrast, conjunction FDR analyses assess
the evidence that either phenotype is non-null. It is therefore
difficult to directly compare the current findings with previous
results. However, of the three identified loci in previous combined
analysis [13,14], both the ITIH3-4 and CACNA1C regions were
confirmed with the conjunctional analyses, but not the ANK3
region. We found the latter to be associated with bipolar disorder
in the current analysis, which suggests that previous results found
with Fisher combined statistics were driven by the stronger
association in bipolar disorder [13,14].
The current findings suggest some interesting gene candidates
related to overlapping biology of bipolar disorder and schizophrenia. The Major Histocompatibility Complex loci associations with
schizophrenia in previous studies [13,17] seem not to be
strengthened by the combined analysis with bipolar disorder, as
they are minimally represented among the current pleiotropic loci
(conjunction FDR analyses). The only pleiotropic gene on
chromosome 6 was NOTCH 4, which has recently also been
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In conclusion, the current findings demonstrate that in
schizophrenia and bipolar disorder, pleiotropy-informed conditional FDR can improve the statistical power for detecting novel
polygenic effects. Results from conditional and conjunction FDR
analyses also offer insights into potential shared mechanistic
relationships between these two mental disorders.

Table 2. Conditional FDR; BD loci given SCZ (BD|SCZ).

locus

SNP

neighbor
gene

Chr

pval BD fdr BD

fdr
BD|SCZ

1

rs2252865

RERE

1p36.23

2.19E-04 0.44657

0.01306

2

rs4650608

IFI44

1p31.1

1.00E-03 0.64629

0.04250

3

rs10776799 NGF

1p13.1

9.68E-06 0.17368

0.02579

4

rs7521783

PLEKHO1

1q21.2

5.58E-04 0.57626

0.02503

5

rs573140

SIPA1L2

1q42.2

6.58E-06 0.15946

0.03009

6

rs3911862

FLJ16124

2p14

5.65E-05 0.26909

0.04864

7

rs2271893

LMAN2L

2q11.2

1.85E-05 0.18928

0.00960

8

rs9834970

TRANK1

3p22.2

5.20E-04 0.57626

0.02711

9

rs2535629

ITIH3{

3p21.1

1.29E-05 0.17896

0.00279

Participant samples

10

rs2902101

ODZ2

5q34

1.04E-04 0.33589

0.03570

11

rs3134942

NOTCH4

6p21.3

1.15E-03 0.66028

0.04844

12

rs9371601

SYNE1{

6q25

1.10E-06 0.06351

0.02196

13

rs3823198

RPS6KA2

6q27

4.16E-05 0.22281

0.01779

14

rs4332037

MAD1

7p22

3.97E-05 0.22281

0.02918

15

rs6461233

MAD1L1

7p22

5.19E-04 0.57626

0.02711

16

rs10277665 THSD7A

7p21.3

5.42E-05 0.24328

0.01641

17

rs6982836

AX747593

8q13.2

5.64E-05 0.26909

0.04168

18

rs7083127

CACNB2

10p12

1.40E-04 0.37364

0.02191

19

rs10994359 ANK3{

10q21

8.12E-10 0.00115 0.00001

20

rs10883757 TRIM8

10q24.3

1.11E-03 0.64629

0.03991

21

rs17138230 ODZ4{

11q14.1

1.43E-05 0.18382

0.03822

22

rs2239037

12p13.3

9.06E-04 0.64629

0.03928

12p13.3

2.42E-07 0.01859 0.00161

We obtained complete GWAS results in the form of summary
statistics p-values from the Psychiatric GWAS Consortium (PGC)
– Schizophrenia and Bipolar Disorder Working Groups. The
schizophrenia (SCZ) GWAS summary statistics results were
obtained from the PGC Schizophrenia Work Group [13], which
consisted of 9,394 cases with schizophrenia or schizoaffective
disorder and 12,462 controls (52% screened) from a total of 17
samples from 11 countries. Semi-structured interviews were used
by trained interviewers to collect clinical information, and
operational criteria were used to establish diagnosis. The quality
of phenotypic data was verified by a systematic review of data
collection methods and procedures at each site, and only studies
that fulfilled these criteria were included. Controls were selected
from the same geographical and ethnic populations as cases. For
further details on sample characteristics and quality control
procedures applied, please see Ripke et al..
The bipolar disorder (BD) GWAS summary statistics results
were obtained from the PGC Bipolar Disorder Working Group
[14], which consisted of n = 16,731 participants, including 7481
cases and 9250 controls, from 11 studies from 7 countries.
Standardized semi-structured interviews were used by trained
interviewers to collect clinical information about lifetime history of
psychiatric illness and operational criteria applied to make lifetime
diagnosis according to recognized classifications. All cases have
experienced pathologically relevant episodes of elevated mood
(mania or hypomania) and meet operational criteria for a BD
diagnosis. The sample consisted of BD I (84%), BD II (11%),
schizoaffective disorder bipolar type (4%), and BD NOS (1%).
Controls were selected from the same geographical and ethnic
populations as cases. For further details on sample characteristics
and quality control procedures applied, please see Sklar et al. [14].
Due to overlapping control samples in these studies, the
common controls were split randomly, and divided between the
two case-control analyses. All results presented here are based on
these non-overlapping control samples, with n = 9379 cases and
n = 7736 control samples in schizophrenia, and n = 6990 cases and
n = 4820 controls in bipolar disorder analyses.

CACNA1C

rs10774037 CACNA1C{
23

rs7296288

12q13.1

2.88E-05 0.20749

0.02777

24

rs12427050 NEDD1

DHH

12q23.1

5.00E-04 0.57626

0.04728

25

rs4390476

SLITRK1

13q31.1

2.03E-04 0.44657

0.03843

26

rs961196

TTC7B

14q32.11

2.96E-04 0.50926

0.01872

27

rs11160562 EML1

14q32

6.93E-04 0.60769

0.03496

28

rs12708772 SHISA9

16p13.12 9.89E-04 0.64629

0.04219

29

rs11863156 AKTIP

16q12.2

7.86E-05 0.30029

0.00865

30

rs1424003

CDH11

16q21

5.54E-05 0.24328

0.01641

31

rs3809646

C16orf7

16q24

5.76E-04 0.60769

0.03171

32

rs281393

RASIP1

19q13.33

5.99E-05 0.26909

0.01293

33

rs159788

BC039673

20p13

6.48E-04 0.60769

0.03080

34

rs3746972

ITGB2

21q22.3

1.42E-04 0.41109

0.04369

35

rs381523

PPM1F

22q11.22

1.28E-03 0.66028

0.04536

Materials and Methods
Ethics statement
The relevant institutional review boards or ethics committees
approved the research protocol of the individual GWAS used in
the current analysis and all human participants gave written
informed consent.

2

For the independent complex or single gene loci (r ,0.2) with SNP(s) with a
conditional FDR (condFDR),0.05 in bipolar disorder (BD) given association with
schizophrenia (SCZ). All independent loci are listed consecutively. Chromosome
location (Chr). All data were first corrected for genomic inflation. BD FDR
values,0.05 are in bold.
{
Same locus identified in previous BD genome-wide association studies.
doi:10.1371/journal.pgen.1003455.t002

Statistical analyses
Analyses implemented here were motivated by previously
published stratified FDR methods [5,37]. However, we found
that stratified empirical cdfs exhibited a high degree of variability.
Instead, we computed empirical cdfs for the first phenotype
conditional on nominal p-values of the second being at or below a
given threshold. These conditional empirical cdfs vary more
smoothly as a function of p-value thresholds in the second
(associated) phenotype than do empirical cdfs employing disjoint
strata. Conditional FDR estimates derived from the conditional

bipolar disorder phenotypes [9]. This possibility warrants further
investigation, but requires samples with more detailed information
on clinical characteristics. In the current analyses we focused on
SNPs, but gene-based pleiotropy is also of interest [10], as is the
use of the current approach for developing methods for risk
prediction across traits. However, these applications require raw
data from individual participants and these data are not currently
available.
PLOS Genetics | www.plosgenetics.org
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Figure 4. ‘‘Conjunction Manhattan plot’’ of conjunction 2log10 (FDR) values for schizophrenia (SCZ) and bipolar disorder (BD). SNPs
with 2log10 (FDR).1.3, (i.e. FDR,0.05) for both SCZ and BD are shown with large points. A black line around the large points indicates the most
significant SNP in each LD block and this SNP was annotated with the closest gene, which is listed above the symbols in each chromosome. The
figure shows the localization of the ‘pleiotropic loci’, and further details are provided in Table 3.
doi:10.1371/journal.pgen.1003455.g004

Table 3. Conjunction FDR; pleiotropic loci in SCZ and BD (SCZ&BD).

locus

SNP

neighbor gene

Chr

A1

A2

conjfdr BD&SCZ

z-score BD

z-score SCZ

1

rs2252865

RERE

1p36.23

T

C

0.030

3.696

3.494

2

rs4650608

IFI44

1p31.1

T

C

0.043

3.289

3.711

4

rs11205362

PRP3

1q21.1

G

A

0.033

3.404

3.262

8

rs9834970

TRANK1

3p22.2

C

T

0.027

3.470

3.965
3.781

9

rs4687657

ITIH4{

3p21.1

G

T

0.028

3.787

11

rs3134942

NOTCH4{

6p21.3

G

T

0.048

3.251

3.571

15

rs3757440

MAD1L1

7p22

A

G

0.031

3.490

3.425

20

rs10883757

TRIM8

10q24.3

C

T

0.040

3.261

3.046

22

rs1006737

CACNA1C{

12p13.3

A

G

0.022

4.553

4.137

26

rs961196

TTC7B

14q32.11

C

T

0.044

3.618

2.960

28

rs12708772

SHISA9

16p13.12

C

T

0.044

3.294

2.955
3.165

31

rs1800359

ZNF276

16q24.3

A

G

0.035

3.329

33

rs159788

BC039673

20p13

G

A

0.034

3.411

23.232

35

rs381523

PPM1F

22q11.22

A

G

0.045

3.220

3.166

Independent complex or single gene loci (r2,0.2) with SNP(s) with a conjunctional FDR (conjFDR),0.05 in schizophrenia (SCZ) and bipolar disorder (BD). All SNPs with a
conjFDR value,0.05 (bidirectional association, i.e. association with SCZ given association with BD (condFDR,0.05) and association with BD given association with SCZ
(condFDR,0.05)) are listed and sorted in each LD block. We defined the most significant SNP in each LD block based on the minimum conjFDR. All independent loci are
listed consecutively, and the same locus number are used as in the condFDR,0.05 results (Table 1). Chromosome (Chr). Z-scores for each pleiotropic locus are provided,
with minor allele (A1) and major allele (A2). All data were first corrected for genomic inflation.
{
Same locus identified in previous BD or SCZ genome-wide association studies.
doi:10.1371/journal.pgen.1003455.t003
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Figure 5. Histograms of absolute z-scores for bipolar disorder (BD, top panels) and schizophrenia (SCZ, bottom panels) for z-scores
$3. Left panels are actual data, whereas right panels are hypothetical realizations from a doubling of effective sample size, generated from mixture
model fits of f(z) = p0f0(z)+(12p0)f1(z) (see Text S1). Black lines are null sub-densities p0f0(z) and red lines are the full mixture densities f(z). The local
false discovery rate is the ratio fdr = p0f0(z)/f(z). Vertical black bars in each plot indicate the cut-points where local fdr#0.05.
doi:10.1371/journal.pgen.1003455.g005

based fdr corroborate the results of the model-free approaches
presented here.

empirical cdfs are a simple extension of Efron’s Empirical Bayes
FDR methods [33].
One advantage of the model-free empirical cdf approach is the
avoidance of bias in conditional FDR estimates from model
misspecification. However, there are inherent limitations to
model-free approaches, especially with respect to inferring
properties of the non-null distribution and, consequently, estimating power to detect non-null effects. We present complementary
model-based analyses in the Supporting Information that estimate
conditional and conjunctional local false discovery rate (fdr) [27].
Results presented in the Supporting Information using this modelPLOS Genetics | www.plosgenetics.org

Genomic control
The empirical null distribution in GWAS is affected by global
variance inflation due to population stratification and cryptic
relatedness [43] and deflation due to over-correction of test
statistics for polygenic traits by standard genomic control methods
[34]. We applied a control method leveraging only intergenic
SNPs which are likely depleted for true associations (Schork et al.,
under review). First, we annotated the SNPs to genic (59UTR, exon,
11
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Figure 6. ROC curves for bipolar disorder (top) and schizophrenia (bottom). Solid black line show the proportion of non-null SNPs declared
significant (sensitivity) for a given local false discovery rate (1-specificity). The corresponding ROC curves for bipolar disorder local FDR conditional on
schizophrenia (top) and schizophrenia local FDR conditional on bipolar disorder (bottom) are given in red. Power resulting from a hypothetical
doubling of effective subject sample size is given by the dashed black lines.
doi:10.1371/journal.pgen.1003455.g006

and divided all test statistics by lGC. The conditional Q-Q plots
for schizophrenia after control for genomic inflation are shown in
Figure S1.

intron, 39UTR) and intergenic regions using information from the
1KGP. As illustrated in Figure S1, there is an enrichment of
functional genic regions in schizophrenia compared to the
intergenic SNP category. We used intergenic SNPs because their
relative depletion of associations suggests that they provide a
robust estimate of true null effects and thus seem a better category
for genomic control than all SNPs. We converted all p-values to zscores and for each phenotype we estimated the genomic inflation
factor lGC for intergenic SNPs. We computed the inflation factor,
lGC as the median z-score squared divided by the expected
median of a chi-square distribution with one degree of freedom
PLOS Genetics | www.plosgenetics.org

Conditional Q–Q plots for assessing pleiotropic
enrichment
To assess pleiotropic enrichment, we used Q-Q plots conditioned on ‘pleiotropic’ effects. For a given associated phenotype,
enrichment for pleiotropic signals is present if the degree of
deflection from the expected null line is dependent on SNP
12
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associations with the second phenotype. We constructed
conditional Q-Q plots of empirical quantiles of nominal
2log10(p) values for SNP association with schizophrenia for all
SNPs, and for subsets of SNPs determined by the nominal pvalues of their association with bipolar disorder being at or
below a given threshold. Specifically, we computed the
empirical cumulative distribution of nominal p-values for a
given phenotype for all SNPs and for SNPs with significance
levels below the indicated cut-offs for the other phenotype
(2log10(p)$0, 2log10(p)$1, 2log10(p)$2, 2log10(p)$3 corresponding to p#1, p#0.1, p#0.01, p#0.001, respectively). The
nominal p-values (2log10(p)) are plotted on the y-axis, and the
empirical quantiles (2log10(q), where q = 1- empirical cdf(p)) are
plotted on the x-axis. To assess for polygenic effects below the
standard GWAS significance threshold, we focused the conditional Q-Q plots on SNPs with nominal 2log10(p),7.3
(corresponding to p.561028).

Conditional statistics—probability of association with
one disorder
We define the conditional FDR as the posterior probability that a
given SNP is null for the first phenotype given that the p-values for
both phenotypes are as small or smaller as the observed p-values.
Formally, this is given by
FDRðp1 jp2 Þ~p0 ðp2 Þp1 =Fðp1 jp2 Þ,

where p1 is the p-value for the first phenotype, p2 is the p-value for
the second, and F(p1 | p2) is the conditional cdf and p0(p2) the
conditional proportion of null SNPs for the first phenotype given
that p-values for the second phenotype are p2 or smaller. Eq. [5]
makes the assumption, reasonable for independent GWAS, that
summary statistics are independent across phenotypes if they are
null for at least one phenotype. We produce a conservative
estimate of FDR(p1 | p2) by setting p0(p2) = 1 and using the
empirical conditional cdf in place of F(p1 | p2) in Eq. [5]. This is a
straightforward generalization of the Empirical Bayes approach
developed by Efron [33]. We assign a conditional FDR value for
schizophrenia given bipolar disorder p-values (denoted by FDR
SCZ | BD) to each SNP by computing conditional FDR estimates on
a grid and interpolating these estimates into a two-dimensional
look-up table (Figure S2). All SNPs with conditional FDR,0.05
(2log10(FDR).1.3) in schizophrenia given association with
bipolar disorder are listed in Table 1 after ‘pruning’ (removing
all SNPs with r2.0.2 based on 1KGP LD structure). We used the
same procedure, in the opposite direction, to assign a conditional
FDR value (denoted as FDR BD|SCZ) for bipolar disorder given
schizophrenia p-values to each SNP. All SNPs with FDR,0.05
(2log10(FDR).1.3) in bipolar disorder given schizophrenia are
listed in Table 2 after pruning. A significance threshold of
FDR,0.05 nominally corresponds to 5 false positives per 100
reported associations. We present a complementary model-based
approach to estimating conditional FDR in the Text S1.

Conditional false discovery rate
Enrichment seen in the conditional Q-Q plots can be directly
interpreted in terms of the FDR. Specifically, for a given p-value
cutoff, the Bayes FDR [33], closely related to the q-value of Storey
[44] is defined as
FDRðpÞ~p0 F0 ðpÞ=FðpÞ,

ð1Þ

where p0 is the proportion of null SNPs, F0 is the null cdf, and F is
the cdf of all SNPs, both null and non-null; see Text S1 for details
on this simple mixture model formulation [33]. Under the null
hypothesis, F0 is the cdf of the uniform distribution on the unit
interval [0,1], so that Eq. [1] reduces to
FDRðpÞ~p0 p=FðpÞ,

ð2Þ

The cdf F can be estimated by the empirical cdf q = Np/N, where
Np is the number of SNPs with p-values less than or equal to p,
and N is the total number of SNPs. Replacing F by q and
replacing p0 with unity in Eq. [2], we get
FDRðpÞ&p=q,

Conjunction statistics—test of association with both
phenotypes
In order to identify which of the SNPs were associated with
schizophrenia and bipolar disorder we used a conjunction FDR
procedure similar to that described for p-value statistics in Nichols
et al. [45]. This minimizes the effect of a single phenotype driving
the common association signal. Conjunction FDR is defined as the
posterior probability that a given SNP is null for both phenotypes
simultaneously when the p-values for both phenotypes are as small
or smaller than the observed p-values. Formally, conjunction FDR
is given by

ð3Þ

which is biased upwards as an estimate of Eq. [2] [33]. If p0 is
close to one, as is likely true for most GWAS, the increase in bias
by setting it to unity in Eq. [3] is minimal. The quantity 1 – p/q, is
therefore biased downward, and hence is a conservative estimate
of the TDR = 1 - FDR. Note, Eq. [3] is the Empirical Bayes
estimate of the Bayesian FDR described by Efron [33]. Referring
to the formulation of the Q-Q plots, we see that Eq. [3] is
equivalent to the nominal p-value divided by the empirical
quantile, as defined earlier. Given the 2log10 construction of the
Q-Q plots we easily obtain
-log10ðFDRðpÞÞ&log10 ðqÞ{log10 ðpÞ

FDRðp1 ,p2 Þ~p0 ðp1 ,p2 ÞF0 ðp1 ,p2 Þ=Fðp1 ,p2 Þ,

ð6Þ

where p0(p1, p2) is the proportion of SNPs null for both
phenotypes simultaneously, F0(p1, p2) = p1 p2 is the joint null cdf,
and F(p1, p2) is the joint overall cdf.
Conditional empirical cdfs provide a model-free method to
obtain conservative estimates of Eq. [6]. This can be seen as
follows. Estimate the conjunction FDR by

ð4Þ

demonstrating that the (conservatively) estimated FDR is directly
related to the horizontal shift of the curves in the conditional Q-Q
plots from the expected line x = y, with a larger shift corresponding
to a smaller FDR. This is illustrated in Figure 1. For each p-value
threshold in the associated trait (e.g. bipolar disorder), we
calculated the conditional TDR as a function of p-value in the
primary trait (e.g. schizophrenia, indicated by different colored
curves) in Figure 1 according to Eq. [4].
PLOS Genetics | www.plosgenetics.org

ð5Þ


FDRSCZ & BD ~max FDRSCZ j BD ,FDRBD j SCZ

ð7Þ

where FDR SCZ | BD and FDR BD | SCZ (the estimated conditional
FDRs described above) are conservative (upwardly biased)
estimates of Eq. [5]. Thus, Eq. [7] is a conservative estimate of
13
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distribution. Both s02 and s12 are estimated from the data (see
Text S1). The local false discovery rate, defined as the posterior
probability that a SNP is non-null given the observed z score, is
given by Efron and Tibshirani [35]

max{p1/F(p1 | p2), p2/F(p2 | p1)} = max{p1 F2(p2)/F(p1, p2), p2
F1(p1)/F(p1, p2)}. For enriched samples, p-values will tend to be
smaller than predicted from the uniform distribution, so that
F1(p1)$p1 and F2(p2)$p2. Hence, max{p1 F2(p2)/F(p1, p2), p2
F2(p1)/F(p1, p2)}$max{p1 p2/F(p1, p2), p2 p1/F(p1, p2)} = p1 p2/
F(p1, p2)$p0(p1, p2) p1 p2/F(p1, p2). The last quantity is precisely
the conjunction FDR defined by Eq. [6]. Thus, Eq. [7] is a
conservative model-free estimate of the conjunction FDR. We
present a complementary model-based approach to estimating
conjunction FDR in the Text S1.
We assigned the conjunction FDR values by interpolation into a
bi-directional two-dimensional look-up table (Figure S3). All SNPs
with conjunction FDR,0.05 (2log10(FDR).1.3) with schizophrenia and bipolar disorder considered jointly are listed in Table 3
(after pruning), together with the corresponding z-scores and
minor alleles. The z-scores were calculated from the p-values and
the direction of effect was determined by the risk allele.

fdrðzi Þ~p0 f 0 ðzi Þ=f ðzi Þ:

ð9Þ

Using this mixture of Gaussians formulation, we can assess relative
power for gene discovery by determining the proportion of nonnull SNPs with local fdr less than a given cut-off, e.g., 0.05. We can
also determine the impact of scaling the effective sample size on
the distribution f1(zi) of non-null SNPs.
We extend this model to a bivariate framework by postulating a
four groups model of bivariate Gaussians. Let zi be the bivariate z
scores for the ith SNP for schizophrenia and bipolar disorder. The
four groups mixture model is given by
f ðzi Þ~p0 f 0 ðzi Þzp1 f 1 ðzi Þzp2 f 2 ðzi Þzp3 f 3 ðzi Þ,

Conditional Manhattan plots
To illustrate the localization of the genetic markers associated
with schizophrenia given their association with bipolar disorder,
and vice versa, we used a ‘Conditional Manhattan plot’, plotting all
SNPs within an LD block in relation to their chromosomal
location. As illustrated in Figure 2 for schizophrenia, the large
points represent the SNPs with conditional FDR,0.05, whereas
the small points represent the non-significant SNPs. All SNPs
without ‘pruning’ (removing all SNPs with r2.0.2 based on 1KGP
LD structure) are shown. The strongest signal in each LD block is
illustrated with a black line around the circles. This was identified
by ranking all SNPs in increasing order, based on the conditional
FDR value for schizophrenia given bipolar disorder, and then
removing SNPs in LD r2.0.2 with any higher ranked SNP. Thus,
the selected locus was the most significantly associated with
schizophrenia in each LD block (Figure 2). A similar procedure
was used in the conditional Manhattan plot for bipolar disorder
given schizophrenia (Figure 3).

ð10Þ

where p0 is the proportion of SNPs which are null for both
phenotypes, p1 and p2 are the proportion of SNPs which are nonnull for schizophrenia and null for bipolar disorder (and vice versa),
and p3 is the proportion of SNPs non-null for both simultaneously.
The component densities f0, f1, f2, and f3 are bivariate Gaussian with
zero mean and variance-covariance matrices estimated from the
data. From model [9], we can compute conditional local fdr, similar
to the conditional FDR described above. We can also determine the
degree of pleiotropy from the estimated value of p3. Details of the
methods for mixture models, local false discovery rate, and estimates
of polygenicity, the degree of pleiotropic overlap, and power are
presented in Text S1 and Figures S4, S5, S6, S7.

Supporting Information
Figure S1 Stratified Q-Q plots of nominal versus empirical log10 p-values of genic vs. intergenic regions, controlling for
genomic inflation in schizophrenia (p,561028). The plots
illustrate the enrichment of genic SNPs compared to all SNPs,
and lack of enrichment for intergenic SNPs. The plot in top panel is
based on uncorrected data, showing inflation (l 1.24). The
intergenic SNPs were used for genomic control. The plot in bottom
panel is based on data after correcting for inflation.
(DOC)

Conjunction Manhattan plots
To illustrate the localization of the pleiotropic genetic markers
associated with both schizophrenia and bipolar disorder, we
present a ‘Conjunction Manhattan plot’, plotting all SNPs with a
significant conjunction FDR within an LD block in relation to
their chromosomal location. As illustrated in Figure 4, the large
points represent the significant SNPs (FDR,0.05), whereas the
small points represent the non-significant SNPs. All SNPs without
‘pruning’ (removing all SNPs with r2.0.2 based on 1KGP LD
structure) are shown, and the strongest signal in each LD block is
illustrated with a black line around the circles. We ranked all SNPs
based on the conjunction statistic and removed SNPs in LD
r2.0.2 with any higher ranked SNP.

Figure S2 Based on the combination of p-value for the SNP in
schizophrenia (SCZ) and bipolar disorder (BD), we assigned a
conditional FDR value for SCZ to each SNP, by interpolation into
a 2-dimensional lookup table. This is shown in upper panel for SCZ
conditioned on BD, denoted FDRSCZ | BD. BD conditioned on
SCZ, denoted FDRBD|SCZ is shown in lower panel. Color scale
refers to FDR values.
(DOC)

Model-based power analyses
While model-free approaches avoid assumptions that may bias
results, it is necessary to take a model-based approach for assessing
the power to detect non-null SNPs [33]. As in Eq. [1], let p0 be the
proportion of null SNPs and let p1 = 12p0 be the proportion of
non-null SNPs. Following Yang et al. [34], the probability density
f(zi) of the test statistic (z score) for the ith SNP is given by

Figure S3 Based on the combination of p-value for the SNP in
schizophrenia (SCZ) given bipolar disorder (BD), and the
combination of p-value for the SNP in BD given SCZ, we
assigned a conjunction FDR value for SCZ and BD to each SNP,
by interpolation into a bi-directional 2-D look up table. This is
denoted FDRBD&SCZ. Color scale refers to FDR values.
(DOC)

f ðzi Þ~p0 f 0 ðzi Þzp1 f 1 ðzi Þ,

ð8Þ

Figure S4 QQ-plot for schizophrenia (SCZ). Dotted lines give

where the null density f0(zi) corresponds to a N(0, s02) distribution
and the non-null density f1(zi) corresponds to a N(0, s02+s12)

marginal fit based on MCMC estimates for the two-groups
mixture model. Dashed line gives null distribution.
(DOC)
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Figure S5 QQ-plot for bipolar disorder (BD). Dotted lines give
marginal fit based on MCMC estimates for the two-groups
mixture model. Dashed line gives null distribution.
(DOC)

Table S1 Associated loci and previous GWAS findings.

(DOC)
Text S1 Supporting statistical methods.

(DOC)

Figure S6 QQ-plot for type 2 diabetes (T2D). Dotted lines give

marginal fit based on MCMC estimates for the two-groups
mixture model. Dashed line gives null distribution.
(DOC)
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